Pentol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pentol

Quick Facts

Property Description
Active ingredient Pentoxifylline (Oxpentifylline)
Form Oral prolonged-release tablets, Solution for intravenous infusion
Pharmacological class Hémorhéologic agent, Methylxanthine derivative
General purpose Enhances blood flow and microcirculation
Origin Synthetic compound

What is Pentol (Pentoxifylline)? Definition and Composition

Pentol is a systemic medicinal entity whose active component is the substance Pentoxifylline, which may also be referred to by its synonym Oxpentifylline. This agent is structurally identified as a synthetic compound derived from the xanthine chemical family. The composition utilizes Pentoxifylline as a single active ingredient, which is clinically recognized for its unique mechanism of action within the circulatory system.

What Pharmacological Class Does Pentol Belong To?

Pentol belongs to the hémorhéologic agent class, a specific pharmacological designation that emphasizes its function in modifying the physical characteristics of blood flow, rather than solely relying on direct vessel dilation. The medication's core action involves optimizing the flow properties of blood by increasing the deformability (flexibility) of red blood cells and reducing the blood's overall viscosity (thickness).

Pentoxifylline is supplied for systemic administration as prolonged-release oral tablets, typically for ongoing management, and a solution for intravenous infusion in ampoules for use in clinical settings.

The General Purpose of This Circulatory System Drug

The general purpose of Pentol is to support and enhance microcirculation throughout the body, particularly in areas where chronic conditions have restricted blood flow. By physically optimizing the blood's ability to move through narrow vessels, the medication facilitates improved transport of oxygen and nutrients. This targeted action on the circulatory system aids in enhancing tissue oxygenation and supports overall function, providing a foundational therapeutic option for addressing circulatory deficits.

What side effects are possible with Pentol?

Possible Side Effects and Safety Information

The official safety documentation for Pentol (Pentoxifylline) outlines adverse reactions grouped by frequency and the body system affected, strictly based on regulatory classifications. The most frequently reported effects are classified as common and typically involve the gastrointestinal and nervous systems. Less frequent effects are also documented, including serious and rare events.

Official Adverse Reaction Categories

Classification System-Organ Classes Examples of Effects
Common Gastrointestinal, Nervous System Nausea, vomiting, dizziness, headache
Uncommon Immune System, Skin Rash, pruritus (itching), urticaria (hives)
Rare Cardiac, Vascular Hypotension, angina pectoris, cardiac arrhythmia
Very Rare Blood, Immune System, Hepatobiliary Aplastic anemia, anaphylactic reactions, cholestasis

Serious adverse reactions listed in regulatory documents include anaphylactic shock or severe anaphylactoid reactions, as well as the risk of severe bleeding, such as retinal or cerebral hemorrhage.

Safety Restrictions and Considerations

The medicine is formally contraindicated in individuals with recent cerebral or extensive retinal hemorrhage, a haemorrhagic diathesis, or known hypersensitivity to pentoxifylline or other methylxanthine derivatives. Caution is advised when the drug is used concomitantly with anticoagulant or antiplatelet agents due to the potential for increased risk of bleeding. Furthermore, the official labeling notes that special considerations apply to patients with severe renal or hepatic impairment, as reduced clearance may lead to increased plasma concentrations of the drug or its metabolites.

Overdose and Emergency Response

Pentol Overdose and When to Seek Help

Overdosage with Pentol (Pentoxifylline) is officially documented to present with distinct clinical manifestations, requiring immediate medical attention. Initial signs of acute overdosage often include nausea, dizziness, tachycardia (fast heart rate), and a significant fall in blood pressure (hypotension). These symptoms are officially listed and warrant prompt action.

Severe systemic outcomes officially listed in regulatory documents involve the neurological and cardiovascular systems. These include convulsions (seizures), loss of consciousness, and marked agitation. A critical, documented sign is vomiting that resembles coffee grounds, which indicates potential gastrointestinal bleeding.

Immediate Action Mandate

Regulatory authorities explicitly state that immediate emergency medical help must be sought if an overdose is suspected or if more than the prescribed amount has been taken. Emergency services should be contacted if the individual has collapsed, experienced a seizure, or cannot be awakened.

Official Overdose Management

It is officially documented that no specific antidote is known for Pentol overdosage. The treatment is mandated to be symptomatic and supportive, with primary attention focused on the cardiovascular system. If ingestion occurred recently, procedures such as gastric lavage or the administration of activated charcoal may be used to reduce systemic absorption. Acute cases may necessitate specific intensive medical monitoring.

Therapeutic Uses of Pentol

The medication is commonly used in conditions presenting with significant symptomatic burden, such as chronic occlusive arterial disease of the limbs. The primary therapeutic use is associated with symptomatic management, which is a therapeutic approach relevant when supportive symptom management is appropriate.

Symptomatic Relief of Intermittent Claudication

This medication is generally used in the long-term, conservative management of Peripheral Arterial Disease (PAD) to help address symptoms related to physical discomfort in the limbs. It assists with managing the pattern of cramping, aching, or fatigue that occurs during walking. The key therapeutic benefit supports general well-being during symptomatic phases.

Supportive Management of Chronic Circulatory Deficits

Pentol is considered relevant in contexts where additional symptomatic support is needed due to chronic circulatory deficits. This is particularly relevant for the management of chronic venous leg ulcers and certain circulation-related wounds, which are conditions where functional stability becomes affected. This application provides support that helps ease the overall symptom load of persistent skin manifestations.


Quick Fact: Relief for Exertional Limb Pain

Pentol is commonly used to help with symptoms that interfere with daily functioning and create noticeable physiological strain, primarily by addressing symptoms related to physical discomfort in the extremities.

Eligibility and Restrictions for Use

This information is based strictly on governmental regulatory documents and applies to the specific formulations of the medicine, which may vary (e.g., ophthalmic drops vs. combination tablets).

Contraindicated Populations (Must Not Use)

  • Hypersensitivity/Allergy: Individuals with a known allergy to the active ingredients (e.g., cyclopentolate, or the components of the combination tablet Pentol D, such as pantoprazole or domperidone).
  • Specific Conditions: The ophthalmic drop formulation (containing cyclopentolate) is absolutely contraindicated for patients with untreated narrow-angle glaucoma and in patients with Down Syndrome.
  • Combination Product: The tablet form (Pentol D) is contraindicated in patients with severe heart-related issues (such as congestive heart failure or irregular heart rhythms), or a prolactin pituitary tumour.

Populations Requiring Special Consideration

  • Age Restrictions: The ophthalmic drop is indicated for use across all age groups, from neonates to adults, for eye infection treatment. The combination tablet (Pentol D) is generally not recommended for use in children under 12 years.
  • Organ Function: Use of the combination tablet requires caution in patients with underlying kidney or liver disease, as dose adjustment may be necessary.
  • Pregnancy and Lactation: Use during pregnancy is generally not recommended unless the potential benefit justifies the risk, as animal studies have shown potential harm. During breastfeeding, caution is advised as the drug components can pass into breast milk; an alternative agent may be preferred, especially for newborns.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Pentol (thiopental sodium) has documented interactions with several classes of medications, primarily affecting central nervous system function and blood pressure. The most critical interactions often involve potentiation of its sedative effects or its direct influence on cardiovascular agents.

Interacting Medicine or Product Class Documented Interaction Effect
Opioid Analgesics Decreased pain-relieving action (antinociception).
Midazolam Enhanced synergistic effect, increasing overall drug activity.
Probenecid Prolonged action of Pentol.
Diazoxide Potential for increased risk of low blood pressure (hypotension).
Aminophylline, Zimelidine These medicines have been associated with antagonism, potentially reducing the effect of Pentol.
Blood Pressure Medications General class interaction; caution is advised due to potential for cumulative blood pressure effects.
Diuretics (Water Pills) General class interaction; caution is advised due to possible influence on cardiovascular stability.

Combinations with other central nervous system depressants, especially those used in premedication, may lead to unexpectedly deep sedation or respiratory depression. Official regulatory documents indicate that the effect of this medication is complex and is not strictly limited by typical metabolic breakdown pathways. Special caution is warranted in patients who have received too much premedication, as this may be a factor in adverse outcomes. It is generally advised that resuscitative equipment and oxygen must be readily available during administration.

Mechanism of Action

How Pentol Works: Mechanism of Action

Pentol (Pentoxifylline) exerts its physiological effects through a dual mechanism that combines molecular signaling modulation with direct optimization of blood flow properties, resulting in altered flow dynamics in the microcirculation.

Modulation of Blood Flow Physics (Hemorheology)

This mechanism centers on the drug's effect on the physical properties of blood, specifically targeting the erythrocyte membrane structure. Pentol and its active metabolites increase the deformability (flexibility) of red blood cells and suppress their aggregation, which in turn reduces the overall viscosity of the blood. This alteration in the blood's physical flow characteristics reduces hydraulic resistance in the smallest blood vessels, leading to altered flow dynamics and changes in tissue oxygen availability.

Enzyme Inhibition and Intracellular Signaling

The drug functions as an inhibitor of Phosphodiesterase (PDE) enzymes, particularly PDE4. By blocking this enzyme, Pentol causes an accumulation of the crucial second messenger, cyclic Adenosine Monophosphate (cAMP), inside various cells. This increased cAMP level is the molecular trigger for the downstream effects, including the modification of red blood cell structure and the promotion of mild vasodilation in certain peripheral vessels, thereby influencing the systemic circulatory dynamics.

️ Anti-Inflammatory and Fibrinolytic Actions

Pentol also modulates the inflammatory pathway by suppressing the synthesis and release of pro-inflammatory mediators, such as Tumor Necrosis Factor-alpha (TNF-alpha), and reducing leukocyte activation. Concurrently, it influences the hemostatic system by promoting fibrinolysis (fibrin breakdown). This dual action modulates vascular signaling and contributes to the flow of blood through the microcirculation, acting alongside the primary hemorheological effects.

Dosage and Administration Information

How Pentol (Pentoxifylline) Is Used

The usage of Pentol includes specific administration routes, standard dosing regimens, and required conditions for intake. The medication is primarily available for systemic administration as extended-release oral tablets and a solution for intravenous infusion in clinical settings.

Administration Guidelines

Feature Guideline
Route of Administration Oral (Extended-release tablets); Intravenous Infusion
Standard Adult Dose Initial dose is typically 400 mg three times a day (TID).
Adjustment Regimen The dose may be reduced to 400 mg twice a day (BID) for maintenance or to address tolerance concerns.
Timing with Meals Oral tablets must be taken with meals or immediately after food.
Tablet Handling Tablets must be swallowed whole and must not be crushed, chewed, or broken.

Population and Duration Rules

There are specific requirements for certain patient groups. For patients with severely impaired renal (kidney) or hepatic (liver) function, a dose reduction is required, often reduced to 400 mg once daily for severe renal impairment. The safety and effectiveness of Pentol have not been established for use in pediatric patients.

Regarding the treatment duration, the drug must be continued for a minimum of at least 8 weeks to allow for proper assessment of the therapeutic effect.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pentol


Evidence for Use in Intermittent Claudication

This section summarizes the body of research, primarily randomized controlled trials and meta-analyses, that explored outcomes related to functional measures like walking distance in adults with stable intermittent claudication.

Research related to Pentol was studied for symptoms of intermittent claudication and has centered primarily on Randomized Controlled Trials (RCTs). These trials were used in research exploring how symptoms change over time, typically by measuring a patient's Pain-Free Walking Distance (PFWD) and Total Walking Distance (TWD) on a treadmill. Findings describe patterns observed in the studies where measurements of walking distances were reported. However, certainty remains low to moderate regarding the consistency and magnitude of these measured outcomes across all trials, and the findings were mixed in some published literature.

Evidence for Supportive Management of Chronic Venous Leg Ulcers

This block will detail the studies, including randomized trials, that have evaluated the use of Pentol as an additional therapy alongside standard care (such as compression) for patients managing chronic venous leg ulcers.

Pentol was evaluated in the supportive management of chronic venous leg ulcers (wounds) in randomized controlled trials. These trials assessed whether Pentol, when added to compression therapy (the standard treatment), could influence the healing process. Research describes patterns of healing rates observed in the studies when Pentol was used as an adjunct to compression therapy, compared to compression therapy alone. The evidence is typically described as being of moderate certainty in scientific reviews. This certainty level is influenced by the established effect of compression therapy, which is the foundational treatment.


Research Gaps and Overall Evidence Consistency

What remains uncertain is the long-term data available for patients. Follow-up durations were limited in many primary trials, meaning that long-term effects are not fully established regarding sustained functional measurements. Evidence quality varies across studies, and methodological issues have been noted, leading to high heterogeneity in findings. This variability means the results were not consistently replicated across all observed studies.

Frequently Asked Questions (FAQ)

Common questions about Pentol (FAQ)

Q: Does Pentol treat the symptoms or address the underlying cause?

According to official product information, Pentol is classified as a hemorheologic agent. This means it works by modifying the physical properties of the blood, such as making red blood cells more flexible, which helps address the underlying physiological issues that restrict blood flow. This circulatory improvement can then lead to a reduction in symptoms associated with the condition it treats.


Q: What general effects should someone expect Pentol to have on their body?

The medication's general purpose is to support and enhance microcirculation by optimizing blood flow properties. Studies indicate that the intended therapeutic effect is improved blood flow to areas like the affected limbs. In conditions like intermittent claudication, this effect correlated with measures like improved walking distance.


Q: Is Pentol classified as a narcotic or controlled substance?

Regulatory agencies classify Pentol (Pentoxifylline) as a methylxanthine derivative. It is not listed as a narcotic or a federally controlled substance in official drug schedules.


Q: Is Pentol considered a first-line treatment for its approved use?

Official documents indicate that Pentol is specifically indicated for the treatment of intermittent claudication. The decision regarding its placement in a therapeutic plan (such as whether it is a first-line or subsequent therapy) is guided by clinical practice guidelines and a healthcare provider's assessment, rather than the drug's label itself.


Q: What is the reported duration of effect for a single administration of Pentol?

The active component of Pentol and its metabolites have a relatively short half-life, which refers to the time it takes for the concentration to decrease by half. For the unchanged drug, the half-life is approximately 0.4 to 0.8 hours, and for the active metabolites, it is about 1 to 1.5 hours. This is why the medication is often formulated as an extended-release tablet.


Q: How will I know if Pentol is having its intended effect?

Studies evaluating the effectiveness of the drug focused on objective measures, such as increases in pain-free walking distance and maximum walking distance. Patients typically continue the medication for at least eight weeks before the therapeutic effect is properly assessed. Any noticeable personal improvement related to the condition is a topic for discussion with a healthcare provider.


Q: Why do some users report the effects of Pentol wear off quickly?

The active compounds themselves have a short half-life. For this reason, Pentol is usually provided as an extended-release tablet, and the required administration schedule is designed to manage this pharmacokinetic property and maintain consistent therapeutic levels.


Q: What is the public information regarding the safety classification of Pentol?

Official safety documents identify specific conditions under which Pentol must not be used (contraindications), such as recent bleeding events (like cerebral or retinal hemorrhage). It is also contraindicated for those with a known hypersensitivity or intolerance to the drug or other methylxanthine derivatives, which are a class of chemicals that includes caffeine.


Q: Do the side effects of Pentol tend to lessen or go away after continued use?

Regulatory information does not make a general statement that all side effects lessen over time. However, it specifically notes that common gastrointestinal effects, such as nausea or vomiting, can be managed. Administration guidelines instruct that the tablets should be taken with meals or immediately after food to help minimize this type of irritation.


Q: Does Pentol have known effects on sleep patterns, such as insomnia or drowsiness?

Official product monographs list several effects that may impact sleep and alertness. These include common nervous system effects such as drowsiness and dizziness, as well as the potential for insomnia and agitation or restlessness.


Q: Can Pentol cause changes in appetite or body weight?

Official reports list weight change as one of the less common adverse drug reactions associated with the use of Pentol. Additionally, other gastrointestinal issues, such as nausea and abdominal discomfort, are reported in regulatory documentation.


Q: Can Pentol cause temporary changes in mood or increased anxiety?

Official regulatory documents list effects related to the central nervous system. These include reported adverse reactions such as anxiety, agitation, confusion, and restlessness.


Q: Is it normal to feel slightly nauseous when first starting Pentol?

Nausea is officially listed as a common side effect of this medication. To help minimize gastrointestinal irritation, regulatory administration guidelines instruct that the tablets must be taken with meals or immediately after food.


Q: What side effects should prompt a person to contact a healthcare provider immediately?

Official safety information lists serious adverse reactions, such as severe allergic reactions (e.g., anaphylactic shock) and the risk of severe bleeding, including retinal or cerebral hemorrhage. These serious effects are described in regulatory documents as being potentially life-threatening or severe.


Q: Does Pentol interact with common non-prescription pain or cold medicines?

Regulatory documents highlight documented interactions with medication classes that affect blood clotting, such as anticoagulants and antiplatelet agents. Although specific over-the-counter medicines are not individually listed, official guidance emphasizes the importance of informing a healthcare provider about all medicines used, including non-prescription products.


Q: Are there any specific food, mineral, or vitamin interactions noted for Pentol?

The primary condition regarding food is that the oral tablets must be taken with meals or immediately after eating, to help manage gastrointestinal side effects. Caution is also advised when combining this medication with supplements that can affect blood clotting, such as Garlic or Ginkgo.


Q: What information is available on interactions between Pentol and herbal supplements?

Regulatory reviews indicate that caution is advised when using Pentol alongside herbal supplements that are known to affect blood clotting. Examples of such supplements mentioned in relation to bleeding risk include Ginkgo and Garlic.


Q: Are there listed interactions between Pentol and common hormonal birth control methods?

Official drug interaction data indicates that certain hormonal contraceptives, specifically those containing ethinyl estradiol, may increase the concentration of Pentol in the blood. This increased level could potentially elevate the risk of experiencing some side effects, such as dizziness or nausea.


Q: What is known about Pentol and its potential interaction with tobacco or nicotine products?

Regulatory information and interaction databases indicate a documented interaction between Pentol and nicotine products. Communication regarding the use of tobacco or nicotine is important to include in discussions with a healthcare provider.


Q: Does Pentol affect the way other medicines are absorbed in the body?

Official product information states that Pentol is processed extensively by the liver and red blood cells through a process called first-pass metabolism. The drug interaction information in regulatory documents focuses primarily on how the combination affects the activity of other drugs or body functions (like blood pressure), rather than providing detailed information about absorption kinetics.


Q: Is it safe to drive or operate heavy machinery while using Pentol?

Official safety documents list side effects that can impair motor skills and judgment, such as dizziness and drowsiness. This is why the product information notes that care should be taken with activities like driving or operating heavy machinery until a person knows how the medication affects them.


Q: Is Pentol generally considered appropriate for use in older adults (geriatric population)?

Clinical studies have not shown significant differences in safety or effectiveness between older and younger patients. However, regulatory documents note that caution is exercised when considering the use of this medication in older adults. This is based on the higher likelihood of existing conditions like decreased kidney, liver, or heart function, which may influence how the drug is handled by the body.

How should Pentol be stored and disposed of?

How to Store and Dispose of Pentol

Official instructions define specific requirements for the storage, handling, and disposal of medicines containing Pentoxifylline.

Storage Conditions

Prolonged-release tablets must be stored at controlled room temperature, specifically between 20 C and 25 C. The tablets should be kept in a tightly closed container, protected from light, and stored in a cool, dry place.

For products prepared as an intravenous solution, the solution must be used within 24 hours of reconstitution and must not be frozen.

Protection and Disposal

The medicine must be stored out of the reach and sight of children. To dispose of unused or expired product, follow the official guidance by using a drug take-back program if available. Pentol must not be flushed down the toilet or poured down any drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pentol found in:

A-Z Index: